Mesoblast Ltd (MESO) stock
MESONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as MEOBF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Aug 27, 2026Score 6/30
$11.91−0.54 (-4.34%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Mesoblast gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2026 it was 86.1%, against 70.2% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | 86.1% | +16.0 |
| FY2025 | Jun 30, 2025 | 70.2% | −29.8 |
| FY2024 | Jun 30, 2024 | 100.0% | +0.0 |
| FY2023 | Jun 30, 2023 | 100.0% | – |
See a number that looks wrong?